• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Health Catalyst Inc

    11/14/24 4:44:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology
    Get the next $HCAT alert in real time by email
    SC 13G 1 hcat-sc13g_093024.htm SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934*

    Health Catalyst, Inc.

    (Name of Issuer)

     
    Common Stock, $0.01 par value

    (Title of Class of Securities)

     
    42225T107

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

      ☒ Rule 13d-1(b)
      ☐ Rule 13d-1(c)
      ☐ Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    CUSIP No. 42225T107   Page 2 of 7

     

    1

    NAME OF REPORTING PERSONS
    First Light Asset Management, LLC

     

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
    (ENTITIES ONLY)

    46-3521994

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

    3 SEC USE ONLY  
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

     

    NUMBER OF
    SHARES

    BENEFICIALLY
    OWNED BY

    EACH
    REPORTING

    PERSON
    WITH:

    5

    SOLE VOTING POWER

    0

     
    6

    SHARED VOTING POWER

    5,248,421

     
    7

    SOLE DISPOSITIVE POWER

    0

     
    8

    SHARED DISPOSITIVE POWER

    5,248,421

     
    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    5,248,421

     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    8.63%

     
    12

    TYPE OF REPORTING PERSON

    IA

     
             

     

     

     

    CUSIP No. 42225T107   Page 3 of 7  
             
    1

    NAME OF REPORTING PERSONS
    Mathew P. Arens

     

    I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
    (ENTITIES ONLY)

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

    3 SEC USE ONLY  
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United State of America

     

    NUMBER OF
    SHARES

    BENEFICIALLY
    OWNED BY

    EACH
    REPORTING

    PERSON
    WITH:

    5

    SOLE VOTING POWER

    0

     
    6

    SHARED VOTING POWER

    5,248,421

     
    7

    SOLE DISPOSITIVE POWER

    0

     
    8

    SHARED DISPOSITIVE POWER

    5,248,421

     
    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    5,248,421

     
    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    8.63%

     
    12

    TYPE OF REPORTING PERSON

    IN

     
                             

     

     

     

    CUSIP No. 42225T107   Page 4 of 7

     

    Item 1(a).   Name of Issuer:
        Health Catalyst, Inc.
         
    Item 1(b).   Address of Issuer’s Principal Executive Offices:
        10897 South River Front Parkway, Suite #300, South Jordan, Utah  84095
         
    Item 2(a).   Name of Person Filing:
       

    This Schedule 13G is being jointly filed by the following:

     

    First Light Asset Management, LLC (the “Manager”)

    Mathew P. Arens (“Mr. Arens”)

       

     

    The Manager may be deemed to be the beneficial owner of 5,248,421 of the Issuer’s shares of common stock (the “Shares”). The Manager acts as an investment adviser to certain persons holding separately managed accounts with the Manager, each of whom has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, those shares. The Manager may be deemed to be the beneficial owner of these shares because it acts as an investment adviser to certain private funds. Mr. Arens may also be deemed to be the beneficial owner of these shares because he controls the Manager in his position as managing member and majority owner of the Manager. The Manager and Mr. Arens are filing this Schedule 13G/A with respect to these Shares pursuant to Rule 13d-1(b) under the Act.

     

    The Manager and Mr. Arens may be deemed to be the beneficial owner of the total amount of Shares set forth across from its or his respective name in Item 4 below. The filing of this Schedule 13G shall not be construed as an admission that the reporting persons or any of their affiliates are the beneficial owner of any securities covered by this Schedule 13G for any other purposes other than Section 13(d) of the Securities Exchange Act of 1934.

         
    Item 2(b).   Address of Principal Business Office or, if None, Residence:
       

    Each of the reporting persons identified in Item 2(a) has its principal business office at:

     

    3300 Edinborough Way, Suite 201, Edina, MN 55435

         
    Item 2(c).   Citizenship:
       

    First Light Asset Management, LLC – Delaware limited liability company

    Mathew P. Arens – United States citizen

         
    Item 2(d).   Title of Class of Securities:
        Common Stock, $0.01 par value
         
    Item 2(e).   CUSIP Number:
        42225T107
         
    Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
      (a) ☐ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
           
      (b) ☐ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ☐ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) ☒ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

     

     

     

     

    CUSIP No. 42225T107   Page 5 of 7
           
      (f) ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) ☒ A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
           
      (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
           
      (j) ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(J).
           
    Item 4. Ownership.
       
      Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
       
      (a) Amount beneficially owned:
       

    First Light Asset Management, LLC – 5,248,421

    Mathew P. Arens – 5,248,421

         
      (b) Percent of class:
       

    First Light Asset Management, LLC – 8.63%

    Mathew P. Arens – 8.63%

     
      (c) Number of shares as to which such person has:
         
        (i) Sole power to vote or to direct the vote
         

    First Light Asset Management, LLC – 0

    Mathew P. Arens – 0

           
        (ii) Shared power to vote or to direct the vote
         

    First Light Asset Management, LLC – 5,248,421

    Mathew P. Arens – 5,248,421

           
        (iii) Sole power to dispose or to direct the disposition of
         

    First Light Asset Management, LLC – 0

    Mathew P. Arens – 0

           
        (iv) Shared power to dispose or to direct the disposition of
         

    First Light Asset Management, LLC – 5,248,421

    Mathew P. Arens – 5,248,421

                 

     

     

     

    CUSIP No. 42225T107   Page 6 of 7

     

    Item 5. Ownership of Five Percent or Less of a Class.
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐
       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
      Not applicable
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
      Not applicable
       
    Item 8. Identification and Classification of Members of the Group.
      Not applicable
       
    Item 9. Notice of Dissolution of Group.
      Not applicable
       
    Item 10. Certification.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    FIRST LIGHT ASSET MANAGEMENT, LLC

     

     
      Date: November 14, 2024  
       
      By: /s/ Kurt T. Peterson  
      Name: Kurt T. Peterson  
      Title: Chief Compliance Officer  
       
     

    Date:

    November 14, 2024

     
     
      Signature: /s/ Mathew P. Arens  
      Name: Mathew P. Arens  

     

     

     

     

    CUSIP No. 42225T107   Page 7 of 7

     

    Exhibit A

    JOINT FILING AGREEMENT

     

     

    The Undersigned agree that the statement on Schedule 13G with respect to the common stock of Health Catalyst, Inc, dated as of November 14, 2024 is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

     

      FIRST LIGHT ASSET MANAGEMENT, LLC
           
      By: /s/ Kurt T. Peterson  
      Name: Kurt T. Peterson  
      Title: Chief Compliance Officer  
           
           
      Signature: /s/ Mathew P. Arens  
      Name: Mathew P. Arens  

      

     

    Get the next $HCAT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCAT

    DatePrice TargetRatingAnalyst
    8/11/2025Buy → Neutral
    Citigroup
    8/8/2025$4.00Overweight → Neutral
    Cantor Fitzgerald
    6/17/2025Buy → Neutral
    BTIG Research
    4/9/2025Outperform → In-line
    Evercore ISI
    1/8/2025$9.00Sector Weight → Overweight
    KeyBanc Capital Markets
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    1/3/2024$14.00Overweight
    Barclays
    1/3/2024$11.00In-line → Outperform
    Evercore ISI
    More analyst ratings

    $HCAT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith S. Dawn was granted 36,231 shares, increasing direct ownership by 55% to 101,692 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/11/25 4:01:06 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Director Gallagher Duncan was granted 36,231 shares, increasing direct ownership by 47% to 113,282 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/10/25 8:17:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Director Hoggard Green Jill was granted 36,231 shares, increasing direct ownership by 131% to 63,937 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    7/10/25 8:17:24 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

    4 - Health Catalyst, Inc. (0001636422) (Issuer)

    2/27/24 4:01:39 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Health Catalyst downgraded by Citigroup

    Citigroup downgraded Health Catalyst from Buy to Neutral

    8/11/25 9:56:17 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00

    8/8/25 8:19:52 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst downgraded by BTIG Research

    BTIG Research downgraded Health Catalyst from Buy to Neutral

    6/17/25 7:47:53 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities

    Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY, Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Health Catalyst Chief Executive Officer Dan Burton is stepping down from his role as CEO, effective June 2026, to enable additional time to pursue a few volunteer service opportunities he and his wife will participate in, in support of their faith, as active members of the Church of Jesus Christ of Latter-Day Saints.

    8/7/25 4:38:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports Second Quarter 2025 Results

    SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. "For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric." said Dan Burton, CEO of Health Catalyst. "I also want to share my plan to retire from the CEO role at Health Catalyst effective June 30, 2026. By then, I will have been leading Health Catalyst full-time

    8/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025

    SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ225." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    7/17/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    SEC Filings

    View All

    SEC Form 10-Q filed by Health Catalyst Inc

    10-Q - Health Catalyst, Inc. (0001636422) (Filer)

    8/8/25 4:13:06 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    8/7/25 4:11:16 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Health Catalyst, Inc. (0001636422) (Filer)

    7/10/25 5:26:18 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Leadership Updates

    Live Leadership Updates

    View All

    Ardent Health Appoints Robert DeMichiei to Board of Directors

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

    4/3/25 5:27:00 PM ET
    $AP
    $ARDT
    $HCAT
    Fluid Controls
    Industrials
    Hospital/Nursing Management
    Health Care

    Modern Health Welcomes Adam Brown as Chief Financial Officer

    Strengthens Executive Team with Seasoned Healthcare Finance Leader Modern Health, a leading global workplace mental health platform, today announces the appointment of Adam Brown as Chief Financial Officer. With an extensive background in healthcare finance and operations, including significant experience scaling high-growth healthcare technology companies, Brown brings deep industry expertise to the company. "Adam is a valued addition to Modern Health's leadership team, and we are thrilled to welcome him on board. His impressive track record and deep understanding of both public and private markets strengthens our executive bench as we continue to execute our vision," said Gyre Renwick

    1/15/25 10:16:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

    SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has signed a definitive agreement to acquire Upfront Healthcare Services, Inc. ("Upfront"), a next-generation patient engagement platform provider. Health Catalyst anticipates the acquisition will close in the first quarter of 2025.Upfront provides a market-leading patient activation and engagement platform and a proprietary strategic marketing analytics and content personalization solution for healthcare enterprises. Upfront's automated patient acquisition and retention solu

    1/13/25 8:00:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Financials

    Live finance-specific insights

    View All

    Health Catalyst Reports Second Quarter 2025 Results

    SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. "For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric." said Dan Burton, CEO of Health Catalyst. "I also want to share my plan to retire from the CEO role at Health Catalyst effective June 30, 2026. By then, I will have been leading Health Catalyst full-time

    8/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025

    SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ225." A live audio webcast will be available online at https://ir.healthcatalyst.com/.

    7/17/25 8:30:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Health Catalyst Reports First Quarter 2025 Results

    SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025. "For the first quarter of 2025, I am pleased by our strong financial results, including total revenue of $79.4 million and Adjusted EBITDA of $6.3 million, with these results beating our quarterly guidance on each metric," said Dan Burton, CEO of Health Catalyst. "Additionally, we are happy to share that we added 10 net new Platform Clients in Q1 2025. This is especially encouraging given that Q1 is typically a quieter bo

    5/7/25 4:03:00 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    $HCAT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 7:51:57 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Health Catalyst Inc

    SC 13G - Health Catalyst, Inc. (0001636422) (Subject)

    11/14/24 4:44:34 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

    SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)

    11/12/24 3:55:05 PM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology